More than a discount: How intelligent copay programmes are r...

Brian Laird explains a more dynamic, data-driven approach to copay is redefining affordability, creating a new standard for balancing patient support.

Why the ‘80/20 Rule’ does NOT rule the specialty pharmaceuti...